Proteonomix, Inc. (OTC.BB:PROT), a biotechnology company focused on developing therapeutics based upon human cells and their derivatives, reported further developments with Proteonomix’s Joint Venture Company, XGEN Medical LLC (”XGen“) towards implementing operations in the United Arab Emirates (U.A.E.).
